Loading organizations...
Loading organizations...
Innovative cell therapy for heart disease treatment and repair.
Metcela has raised $30.7M across 3 funding rounds.
Metcela has raised $30.7M in total across 3 funding rounds.
Metcela has raised $30.7M in total across 3 funding rounds.
Metcela's investors include CYBERDYNE, Japan Lifeline, Reazon Holdings, Sony, University of Tokyo Edge Capital, Alfresa, Dai-ichi Life, KSP, MAKOTO Capital, Tsukuba Exceed Fund, Kenji Yamada.
Metcela has raised $30.7M across 3 funding rounds. Most recently, it raised $14.0M Series C in July 2022.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Jul 5, 2022 | $14.0M Series C | CYBERDYNE | Japan Lifeline, Reazon Holdings, Sony |
| Jan 4, 2021 | $12.7M Series B | University of Tokyo Edge Capital | Alfresa, Dai-ichi Life, Japan Lifeline, KSP, MAKOTO Capital, Sony, Tsukuba Exceed Fund |
| May 20, 2020 | $4.0M Series B | Kenji Yamada, Sony, Tsukuba Exceed Fund |